• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDK5RAP1介导的线粒体tRNA中N6-异戊烯基腺苷的2-甲硫基转化促进胶质瘤起始细胞的维持。

2-Methylthio Conversion of N6-Isopentenyladenosine in Mitochondrial tRNAs by CDK5RAP1 Promotes the Maintenance of Glioma-Initiating Cells.

作者信息

Yamamoto Takahiro, Fujimura Atsushi, Wei Fan-Yan, Shinojima Naoki, Kuroda Jun-Ichiro, Mukasa Akitake, Tomizawa Kazuhito

机构信息

Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan; Department of Neurosurgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.

Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan; Department of Physiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan; Neutron Therapy Research Center, Okayama University, Okayama 700-8558, Japan.

出版信息

iScience. 2019 Nov 22;21:42-56. doi: 10.1016/j.isci.2019.10.012. Epub 2019 Oct 8.

DOI:10.1016/j.isci.2019.10.012
PMID:31654853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6820277/
Abstract

2-Methylthio-N-isopentenyl modification of adenosine (msiA) is an evolutionally conserved modification found in mitochondrial (mt)-tRNAs. Cdk5 regulatory subunit-associated protein 1 (CDK5RAP1) specifically converts N6-isopentenyladenosine (iA) to msiA at position A37 of four mt-DNA-encoded tRNAs, and the modification regulates efficient mitochondrial translation and energy metabolism in mammals. Here, we report that the ms conversion mediated by CDK5RAP1 in mt-tRNAs is required to sustain glioma-initiating cell (GIC)-related traits. CDK5RAP1 maintained the self-renewal capacity, undifferentiated state, and tumorigenic potential of GICs. This regulation was not related to the translational control of mt-proteins. CDK5RAP1 abrogated the antitumor effect of iA by converting iA to msiA and protected GICs from excessive autophagy triggered by iA. The elevated activity of CDK5RAP1 contributed to the amelioration of the tumor-suppressive effect of iA and promoted GIC maintenance. This work demonstrates that CDK5RAP1 is crucial for the detoxification of endogenous iA and that GICs readily utilize this mechanism for survival.

摘要

腺苷的2-甲硫基-N-异戊烯基修饰(msiA)是一种在线粒体(mt)-tRNA中发现的进化保守修饰。细胞周期蛋白依赖性激酶5调节亚基相关蛋白1(CDK5RAP1)特异性地将四种线粒体DNA编码的tRNA第37位的N6-异戊烯基腺苷(iA)转化为msiA,这种修饰调节哺乳动物中高效的线粒体翻译和能量代谢。在此,我们报告mt-tRNA中由CDK5RAP1介导的ms转化是维持胶质瘤起始细胞(GIC)相关特征所必需的。CDK5RAP1维持了GIC的自我更新能力、未分化状态和致瘤潜力。这种调节与mt蛋白的翻译控制无关。CDK5RAP1通过将iA转化为msiA消除了iA的抗肿瘤作用,并保护GIC免受iA触发的过度自噬。CDK5RAP1活性的升高有助于减轻iA的肿瘤抑制作用并促进GIC的维持。这项工作表明CDK5RAP1对内源性iA的解毒至关重要,并且GIC很容易利用这种机制来生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/90ba038155fe/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/a37a5246e5d0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/0389882c34a7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/8db9582bf322/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/5a6c70d7101a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/a7c767bc58e4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/8f4b226c8d83/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/90ba038155fe/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/a37a5246e5d0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/0389882c34a7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/8db9582bf322/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/5a6c70d7101a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/a7c767bc58e4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/8f4b226c8d83/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8425/6820277/90ba038155fe/gr6.jpg

相似文献

1
2-Methylthio Conversion of N6-Isopentenyladenosine in Mitochondrial tRNAs by CDK5RAP1 Promotes the Maintenance of Glioma-Initiating Cells.CDK5RAP1介导的线粒体tRNA中N6-异戊烯基腺苷的2-甲硫基转化促进胶质瘤起始细胞的维持。
iScience. 2019 Nov 22;21:42-56. doi: 10.1016/j.isci.2019.10.012. Epub 2019 Oct 8.
2
Cdk5rap1-mediated 2-methylthio-N6-isopentenyladenosine modification is absent from nuclear-derived RNA species.细胞核来源的RNA种类不存在Cdk5rap1介导的2-甲硫基-N6-异戊烯基腺苷修饰。
Nucleic Acids Res. 2017 Nov 16;45(20):11954-11961. doi: 10.1093/nar/gkx819.
3
The CDK5 repressor CDK5RAP1 is a methylthiotransferase acting on nuclear and mitochondrial RNA.CDK5 抑制剂 CDK5RAP1 是一种甲基硫转移酶,作用于核仁和线粒体 RNA。
Nucleic Acids Res. 2012 Jul;40(13):6235-40. doi: 10.1093/nar/gks240. Epub 2012 Mar 15.
4
Cdk5rap1-mediated 2-methylthio modification of mitochondrial tRNAs governs protein translation and contributes to myopathy in mice and humans.Cdk5rap1 介导的线粒体 tRNA 的 2-甲硫基修饰调控蛋白质翻译,并导致小鼠和人类的肌肉疾病。
Cell Metab. 2015 Mar 3;21(3):428-42. doi: 10.1016/j.cmet.2015.01.019.
5
CDK5RAP1 targeting NF-κB signaling pathway in human malignant melanoma A375 cell apoptosis.CDK5RAP1靶向核因子-κB信号通路诱导人恶性黑色素瘤A375细胞凋亡。
Oncol Lett. 2018 Apr;15(4):4767-4774. doi: 10.3892/ol.2018.7920. Epub 2018 Feb 1.
6
Regulation of aromatic amino acid transport by tRNA: role of 2-methylthio-N6-(delta2-isopentenyl)-adenosine.tRNA对芳香族氨基酸转运的调控:2-甲硫基-N6-(δ2-异戊烯基)-腺苷的作用
Nucleic Acids Res. 1981 Jan 24;9(2):401-14. doi: 10.1093/nar/9.2.401.
7
Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.Notch1 信号通路通过调节趋化因子系统 CXCL12/CXCR4 促进胶质瘤起始细胞的侵袭、自我更新和生长。
J Exp Clin Cancer Res. 2019 Aug 5;38(1):339. doi: 10.1186/s13046-019-1319-4.
8
Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation.自噬抑制神经胶质瘤起始细胞的自我更新能力和致瘤性,并促进 Notch1 的降解。
Cell Death Dis. 2018 Oct 18;9(11):1063. doi: 10.1038/s41419-018-0957-3.
9
Identification of 2-Methylthio-methylenethio-N -(cis-4-hydroxyisopentenyl)adenosine (msms io A ) as a Novel Modification at Adenosine 37 of tRNAs from Salmonella typhimurium.鉴定2-甲硫基-亚甲基硫代-N-(顺式-4-羟基异戊烯基)腺苷(msms io A)为鼠伤寒沙门氏菌tRNA腺苷37位的一种新型修饰。
Chembiochem. 2023 Mar 14;24(6):e202300019. doi: 10.1002/cbic.202300019. Epub 2023 Feb 20.
10
Noninvasive diagnosis of TRIT1-related mitochondrial disorder by measuring i A37 and ms i A37 modifications in tRNAs from blood and urine samples.通过测量血液和尿液样本中 tRNA 的 iA37 和 msiA37 修饰物,实现 TRIT1 相关线粒体疾病的无创诊断。
Am J Med Genet A. 2019 Aug;179(8):1609-1614. doi: 10.1002/ajmg.a.61211. Epub 2019 May 29.

引用本文的文献

1
Changes in adrenoceptor expression level contribute to the cellular plasticity of glioblastoma cells.肾上腺素能受体表达水平的变化有助于胶质母细胞瘤细胞的细胞可塑性。
J Physiol Sci. 2025 Mar 28;75(2):100016. doi: 10.1016/j.jphyss.2025.100016.
2
Decoding Codon Bias: The Role of tRNA Modifications in Tissue-Specific Translation.解读密码子偏好性:tRNA修饰在组织特异性翻译中的作用
Int J Mol Sci. 2025 Jan 15;26(2):706. doi: 10.3390/ijms26020706.
3
The role of C1orf50 in breast cancer progression and prognosis.C1orf50在乳腺癌进展和预后中的作用。

本文引用的文献

1
Reduction of Movement in Neurological Diseases: Effects on Neural Stem Cells Characteristics.神经系统疾病中运动减少对神经干细胞特性的影响
Front Neurosci. 2018 May 23;12:336. doi: 10.3389/fnins.2018.00336. eCollection 2018.
2
A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells.一种针对胶质瘤细胞中缺氧诱导的化疗耐药性和干性的联合药物。
Oncotarget. 2018 Apr 6;9(26):18351-18366. doi: 10.18632/oncotarget.24839.
3
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux.
Breast Cancer. 2025 Mar;32(2):292-305. doi: 10.1007/s12282-024-01653-8. Epub 2024 Nov 28.
4
Advancements in mitochondrial-targeted nanotherapeutics: overcoming biological obstacles and optimizing drug delivery.线粒体靶向纳米治疗学的进展:克服生物学障碍和优化药物传递。
Front Immunol. 2024 Oct 17;15:1451989. doi: 10.3389/fimmu.2024.1451989. eCollection 2024.
5
Inflammation-induced epigenetic imprinting regulates intestinal stem cells.炎症诱导的表观遗传印记调控肠道干细胞。
Cell Stem Cell. 2024 Oct 3;31(10):1447-1464.e6. doi: 10.1016/j.stem.2024.08.006. Epub 2024 Sep 3.
6
Adrenergic microenvironment driven by cancer-associated Schwann cells contributes to chemoresistance in patients with lung cancer.由癌症相关雪旺细胞驱动的肾上腺素能微环境有助于肺癌患者的化疗耐药。
Cancer Sci. 2024 Jul;115(7):2333-2345. doi: 10.1111/cas.16164. Epub 2024 Apr 27.
7
The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues.tRNA修饰对癌症翻译的影响:确定新的治疗途径。
NAR Cancer. 2024 Mar 12;6(1):zcae012. doi: 10.1093/narcan/zcae012. eCollection 2024 Mar.
8
Connective tissue mast cells store and release noradrenaline.结缔组织肥大细胞储存并释放去甲肾上腺素。
J Physiol Sci. 2023 Oct 12;73(1):24. doi: 10.1186/s12576-023-00883-3.
9
Research Advances on Deafness Genes Associated with Mitochondrial tRNA-37 Modifications.耳聋基因与线粒体 tRNA-37 修饰相关的研究进展。
J Int Adv Otol. 2023 Oct;19(5):414-419. doi: 10.5152/iao.2023.231107.
10
CDKAL1 Drives the Maintenance of Cancer Stem-Like Cells by Assembling the eIF4F Translation Initiation Complex.CDKAL1 通过组装 eIF4F 翻译起始复合物来驱动癌症干细胞样细胞的维持。
Adv Sci (Weinh). 2023 Apr;10(12):e2206542. doi: 10.1002/advs.202206542. Epub 2023 Feb 14.
N6-异戊烯基腺苷双重靶向 AMPK 和 Rab7 异戊烯化抑制黑色素瘤生长,通过损害自噬通量。
Cell Death Differ. 2018 Feb;25(2):353-367. doi: 10.1038/cdd.2017.165. Epub 2017 Oct 13.
4
Cdk5rap1-mediated 2-methylthio-N6-isopentenyladenosine modification is absent from nuclear-derived RNA species.细胞核来源的RNA种类不存在Cdk5rap1介导的2-甲硫基-N6-异戊烯基腺苷修饰。
Nucleic Acids Res. 2017 Nov 16;45(20):11954-11961. doi: 10.1093/nar/gkx819.
5
The modified base isopentenyladenosine and its derivatives in tRNA.tRNA 中的修饰碱基异戊烯基腺苷及其衍生物。
RNA Biol. 2017 Sep 2;14(9):1197-1208. doi: 10.1080/15476286.2017.1294309. Epub 2017 Feb 17.
6
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.内源性类异戊二烯终产物N6-异戊烯基腺苷通过下调表皮生长因子受体产生的抗胶质瘤作用
Int J Cancer. 2017 Feb 15;140(4):959-972. doi: 10.1002/ijc.30505. Epub 2016 Nov 16.
7
Divergent transcription and epigenetic directionality of human promoters.人类启动子的发散转录和表观遗传方向性
FEBS J. 2016 Dec;283(23):4214-4222. doi: 10.1111/febs.13747. Epub 2016 May 11.
8
Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.利用表观基因组控制癌症促进基因表达程序。
Cancer Cell. 2016 Apr 11;29(4):464-476. doi: 10.1016/j.ccell.2016.03.007.
9
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.mTOR抑制可降低SOX2 - SOX9介导的胶质瘤干细胞活性及替莫唑胺耐药性。
Expert Opin Ther Targets. 2016;20(4):393-405. doi: 10.1517/14728222.2016.1151002.
10
Mitochondrial Cristae: Where Beauty Meets Functionality.线粒体嵴:美观与功能的完美结合。
Trends Biochem Sci. 2016 Mar;41(3):261-273. doi: 10.1016/j.tibs.2016.01.001. Epub 2016 Feb 6.